Is self-administered DMPA an answer to contraception access in the post-Roe era?

View/Open
Date
2023-03
Format
Metadata
[+] Show full item record
Abstract
Is self-administered DMPA an answer to contraception access in the post-Roe era? Compared with provider-administered depot medroxyprogesterone acetate, a prefilled formulation may offer patients improved access to effective contraception.
URI
https://hdl.handle.net/10355/102184
https://doi.org/10.12788/jfp.0558
Part of
Citation
J Fam Pract. 2023 March;72(2):84-86
Rights
OpenAccess.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
Collections